mechanism of glp 1 agonist The Impact GLP-1 Receptor Agonists on Ocular Disease Incretin-based therapy of metabolic disease

The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application

Healthy fats Fat gets a bad rap, but not all types of dietary fat are the same

(2014c)

This development has major implications for how we approach obesity treatment and by proxy sleep apnea management

In 14 RCTs, 11 of which were obtained from Chinese databases, involving 1126 participants, the metformin group gained on average 3.12 kg, (95% CI 4.22 kg to 2.01 kg) less than control

Diabetes mellitus (DM) is a major risk factor CVDs and is also associated with a higher risk of graft failure [5, 6]